Upstream Bio, Inc. ( UPB) - Key Metrics
UPB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.73 | -$0.65 | -$0.65 |
| 2026Q1 | $0.02 | -$0.75 | -$0.88 | -$0.88 |
| 2025Q4 | $0.01 | -$0.78 | -$0.56 | -$0.57 |
| 2025Q3 | $0.01 | -$0.63 | -$0.41 | -$0.41 |
| 2025Q2 | $0.02 | -$0.74 | -$0.73 | -$0.73 |
UPB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.37 |
| 2026Q1 | 0% | -3 |
| 2025Q4 | 0% | -8.59 |
| 2025Q3 | 0% | -7.46 |
| 2025Q2 | 0% | -3.71 |
UPB
Price: $6.85
52 week price:
Earnings Per Share: -6.31 USD
P/E Ratio: -1.22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 373.9 million